Priority Review of Drug Submissions (Therapeutic Products) (French, HTML)
Priority Review of Drug Submissions (Therapeutic Products): French HTML file. From Health Canada, updated Sep 2023. View metadata, licence and the direct download on CanQuery.
- Format
- HTML
- Access
- Original download only
- Publisher-reported update
- 2023-09-03
Priority Review is a fast-track status granted to eligible new drug submissions for human use, following review and approval of a request submitted by the sponsor of the drug. Priority Review submissions are introduced into Health Canada's drug review queue in accordance with an accelerated review target of 180 days.
Data overview
- Formats
- HTML
- File languages
- French
- Available actions
- Access original file